13G Filing: Intracoastal Capital, LLC and Apricus Biosciences Inc. (APRI)

Item
1.

 

(a)
Name of Issuer

 

Apricus
Biosciences, Inc. (the “Issuer”)

 

(b)
Address of Issuer’s Principal Executive Offices

 

11975
El Camino Real, Suite 300

San
Diego, California 92130

 

Item
2.

 

(a)
Name of Person Filing

(b)
Address of Principal Business Office or, if none, Residence

(c)
Citizenship

 

This
Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual who is a citizen of the United States of America
(“Mr. Kopin”), (ii) Daniel B. Asher, an individual who is a citizen of the United States of America (“Mr.
Asher”) and (iii) Intracoastal Capital LLC, a Delaware limited liability company (“Intracoastal”
and together with Mr. Kopin and Mr. Asher, collectively the “Reporting Persons”).

 

The
Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit
1, pursuant to which the Reporting Persons have agreed to file this Schedule 13G jointly in accordance with the provisions
of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended.

 

The
principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483.

 

The
principal business office of Mr. Asher is 111 W. Jackson Boulevard, Suite 2000, Chicago, Illinois 60604.

 

(d)
Title of Class of Securities

 

Common
stock, $0.001 par value per share, of the Issuer (the “Common Stock”).

 

(e)
CUSIP Number

 

03832V307

 

Item
3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is
a:

 

Not
applicable.